AVTE
Price
$2.66
Change
-$0.02 (-0.75%)
Updated
Apr 28, 02:16 PM (EDT)
Capitalization
77.68M
21 days until earnings call
ENTBF
Price
$0.08
Change
+$0.02 (+33.33%)
Updated
Apr 23 closing price
Capitalization
1.2M
Ad is loading...

AVTE vs ENTBF

Header iconAVTE vs ENTBF Comparison
Open Charts AVTE vs ENTBFBanner chart's image
Aerovate Therapeutics
Price$2.66
Change-$0.02 (-0.75%)
Volume$550
Capitalization77.68M
ENTHEON BIOMEDICAL
Price$0.08
Change+$0.02 (+33.33%)
Volume$313
Capitalization1.2M
AVTE vs ENTBF Comparison Chart
Loading...
AVTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTE vs. ENTBF commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTE is a Hold and ENTBF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (AVTE: $2.68 vs. ENTBF: $0.08)
Brand notoriety: AVTE and ENTBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTE: 396% vs. ENTBF: 10%
Market capitalization -- AVTE: $77.68M vs. ENTBF: $1.2M
AVTE [@Biotechnology] is valued at $77.68M. ENTBF’s [@Biotechnology] market capitalization is $1.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTE’s FA Score shows that 0 FA rating(s) are green whileENTBF’s FA Score has 0 green FA rating(s).

  • AVTE’s FA Score: 0 green, 5 red.
  • ENTBF’s FA Score: 0 green, 5 red.
According to our system of comparison, both AVTE and ENTBF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTE’s TA Score shows that 7 TA indicator(s) are bullish.

  • AVTE’s TA Score: 7 bullish, 4 bearish.

Price Growth

AVTE (@Biotechnology) experienced а +728.36% price change this week, while ENTBF (@Biotechnology) price change was +33.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.75%. For the same industry, the average monthly price growth was +0.72%, and the average quarterly price growth was -9.37%.

Reported Earning Dates

AVTE is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+10.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVTE($77.7M) has a higher market cap than ENTBF($1.2M). AVTE YTD gains are higher at: 759.623 vs. ENTBF (-38.483). ENTBF has higher annual earnings (EBITDA): -403.94K vs. AVTE (-74.31M). AVTE has more cash in the bank: 3.96M vs. ENTBF (525K). AVTE (0) and ENTBF (0) have equivalent revenues.
AVTEENTBFAVTE / ENTBF
Capitalization77.7M1.2M6,480%
EBITDA-74.31M-403.94K18,398%
Gain YTD759.623-38.483-1,974%
P/E RatioN/AN/A-
Revenue00-
Total Cash3.96M525K754%
Total Debt417KN/A-
TECHNICAL ANALYSIS
Technical Analysis
AVTE
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
87%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
View a ticker or compare two or three
Ad is loading...
AVTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KGSPY85.534.28
+5.26%
Kingspan Group plc.
SMCAY16.410.61
+3.86%
SMC Corp
MGPI29.190.22
+0.76%
MGP Ingredients
PNNT6.470.02
+0.31%
Pennant Investment Corp
CRVO8.64-0.16
-1.82%
CervoMed

AVTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTE has been closely correlated with OVID. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if AVTE jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTE
1D Price
Change %
AVTE100%
+737.50%
OVID - AVTE
71%
Closely correlated
+3.00%
NTLA - AVTE
46%
Loosely correlated
+1.59%
DNLI - AVTE
43%
Loosely correlated
+1.23%
BEAM - AVTE
41%
Loosely correlated
-3.22%
SNDX - AVTE
39%
Loosely correlated
+0.23%
More

ENTBF and

Correlation & Price change

A.I.dvisor tells us that ENTBF and AVTE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ENTBF and AVTE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTBF
1D Price
Change %
ENTBF100%
N/A
AVTE - ENTBF
32%
Poorly correlated
+737.50%
OVID - ENTBF
23%
Poorly correlated
+3.00%
IMRN - ENTBF
22%
Poorly correlated
+4.20%
HSTC - ENTBF
22%
Poorly correlated
+10.67%
ATNF - ENTBF
21%
Poorly correlated
+2.33%
More